Apotex Inc. -4100 Weston Road Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Apotex Inc. -4100 Weston Road Pharmaceutical Import Records from India — 2 Products, $5.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Apotex Inc. -4100 Weston Road — Pharmaceutical Importer Profile (2026) | 2 Products, $5.0M Trade | TransData Nexus

Apotex Inc. -4100 Weston Road

Pharmaceutical Importer · Canada · Cardiovascular Focus · $5.0M Total Trade · DGFT Verified

Apotex Inc. -4100 Weston Road is a pharmaceutical importer based in Canada with a total trade value of $5.0M across 2 products in 1 therapeutic categories. Based on 106 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Apotex Inc. -4100 Weston Road sources from 1 verified Indian supplier, with Apotex Research Private Limited accounting for 100.0% of imports.

Apotex Inc. -4100 Weston Road — Import Portfolio & Supplier Network

Apotex Inc. -4100 Weston Road import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Apotex Inc. -4100 Weston Road?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Apotex Research Private Limited	$5.6M	157	100.0%

Apotex Inc. -4100 Weston Road sources from 1 verified Indian supplier across 130 distinct formulations. The sourcing is highly concentrated — Apotex Research Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Apotex Inc. -4100 Weston Road Import?

Formulation	Value	Ships
Apo-rosuvastatin fct 10MG 30 bls	$103.0K	3
Apo-apixaban fct 5MG 500 btl 68198/771313253444 batch lot	$100.0K	2
Apo-ticagrelor fct 90MG 180 btl 69940/771313257343 batch lot	$100.0K	2
Apo-ticagrelor fct 90MG 180 btl 69940/771313257343 batch lot	$100.0K	2
Apo-ticagrelor fct 90MG 180 btl 69940/771313257343 batch lot	$100.0K	2
Apo-apixaban fct 5MG 500 btl 68198/771313253444 batch lot	$100.0K	2
Apo-apixaban fct 5MG 500 btl 68198/771313253444 batch lot	$100.0K	2
Apo-apixaban fct 2.5MG 60 btl 69010 /	$94.1K	3
Apo-atorvastatin fct 40MG 100 btl 51634/	$79.5K	3
Apo-acetaminophen 325 MG TAB 100 u/d	$77.0K	3
Apo-acetaminophen 325 MG TAB 100 u/d	$76.7K	3
Apo-acetaminophen 325 MG TAB 100 u/d	$75.8K	3
Apo-naproxen 250 MG TAB 100 btl 41588	$74.9K	3
Apixaban fct 5MG 500 btl siv 70038 / 628003007880 batch lot	$50.0K	1
Apo- apixaban fct 5MG 500 btl 69305/ 771313255714 batch lot	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Apixaban	Cardiovascular	$4.5M	96	1.3%	8
2	Rivaroxaban	Cardiovascular	$499.7K	10	1.0%	16

Apotex Inc. -4100 Weston Road imports 2 pharmaceutical products across 1 categories into Canada totaling $5.0M.

Apotex Inc. -4100 Weston Road — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Apotex Inc., headquartered at 4100 Weston Road, Toronto, Ontario, Canada, is a leading Canadian pharmaceutical company specializing in the production and distribution of generic medications. Established in 1974 by Barry Sherman, Apotex has grown to become Canada's largest drug manufacturer, employing approximately 8,000 individuals and offering over 300 products across more than 115 countries. The company's extensive portfolio includes treatments for various health conditions such as cancer, diabetes, high cholesterol, glaucoma, infections, and hypertension.

Apotex operates through three primary divisions: Research & Development, Manufacturing, and Sales & Marketing. The Research & Development division encompasses biosimilars, while the Manufacturing division oversees the production of both active pharmaceutical ingredients (APIs) and finished dosage forms. The Sales & Marketing division is responsible for promoting and distributing Apotex's products globally. In 2023, the company reported worldwide sales exceeding $1.9 billion, underscoring its significant presence in the global pharmaceutical market.

2Distribution Network

Apotex's distribution network is extensive, with operations spanning across Canada and into international markets. The company maintains manufacturing and distribution facilities in cities such as Montreal, Richmond Hill, Toronto, Etobicoke, Mississauga, Brantford, Windsor, Winnipeg, London, Calgary, and Vancouver. This widespread presence enables Apotex to efficiently supply its products to a diverse customer base, including pharmacies, hospitals, and healthcare providers. The company's logistics capabilities are robust, ensuring timely delivery of pharmaceutical products both domestically and internationally. Apotex's global reach is further supported by its network of joint ventures, affiliates, strategic alliances, and distributors, facilitating the distribution of its products in over 115 countries.

3Industry Role

Apotex Inc. - 4100 Weston Road serves as a primary wholesaler and distributor within Canada's pharmaceutical supply chain. The company's extensive manufacturing capabilities allow it to produce a wide range of generic medications, which are then distributed to various healthcare providers, including pharmacies, hospitals, and clinics. Apotex's role as a wholesaler is integral to ensuring the availability of affordable generic drugs in the Canadian market, thereby enhancing access to essential medications for patients. Additionally, Apotex's international operations contribute to its position as a significant player in the global pharmaceutical industry.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Apotex Inc. -4100 Weston Road

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Apotex's sourcing strategy exhibits a high degree of concentration, with a total import value from India amounting to $5.0 million USD across 106 shipments. The company's imports from India are exclusively finished pharmaceutical formulations, including Apixaban and Rivaroxaban, both anticoagulants used in cardiovascular treatments. This focused sourcing approach suggests a strategic decision to leverage India's manufacturing capabilities for specific high-demand products. The reliance on a single supplier, APOTEX RESEARCH PRIVATE LIMITED, for all 157 shipments indicates a strong, stable relationship, which is crucial for maintaining consistent product quality and supply chain reliability. However, this single-source dependency also presents potential risks, such as supply disruptions due to unforeseen events affecting the supplier.

The shipment data reveals a consistent pattern in Apotex's imports from India, with no significant fluctuations or irregularities observed. This stability reflects a well-established and dependable supply chain relationship. The concentration on two primary products within the cardiovascular therapeutic category further underscores Apotex's strategic focus on meeting specific market demands. While this approach allows for streamlined operations and potential cost efficiencies, it also highlights the importance of ensuring the resilience and reliability of the supply chain to mitigate any risks associated with supplier dependency.

2Supply Chain Resilience

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the primary regulatory authority overseeing pharmaceutical imports is Health Canada, which is responsible for ensuring that all drugs entering the Canadian market meet safety, efficacy, and quality standards. The Food and Drugs Act and its associated regulations provide the legislative framework governing the importation, distribution, and sale of pharmaceutical products in Canada. Health Canada's Therapeutic Products Directorate (TPD) evaluates and approves new drugs, including generics, before they can be marketed.

For Indian pharmaceutical companies seeking to export to Canada, obtaining a Drug Establishment License (DEL) from Health Canada is mandatory. This license certifies that the foreign manufacturer complies with Canadian Good Manufacturing Practices (GMP) and is authorized to sell drugs in Canada. The approval process involves a thorough review of the manufacturer's facilities, quality control systems, and product dossiers to ensure compliance with Canadian standards.

2Import Licensing & GMP

Import licensing in Canada requires foreign manufacturers to obtain a Drug Establishment License (DEL) from Health Canada. This license is essential for the importation and sale of pharmaceutical products within the country. To qualify for a DEL, manufacturers must demonstrate compliance with Canadian Good Manufacturing Practices (GMP), which are aligned with international standards such as EU GMP, WHO GMP, and PIC/S. These standards ensure that pharmaceutical products are consistently produced and controlled to quality standards appropriate for their intended use.

Apotex Inc. -4100 Weston Road — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Apotex's focus on importing finished pharmaceutical formulations, particularly Apixaban and Rivaroxaban, aligns with the company's strategic emphasis on the cardiovascular therapeutic category. This focus is driven by the high prevalence of cardiovascular diseases and the corresponding demand for effective treatments.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Apotex Inc. -4100 Weston Road

What products does Apotex Inc. -4100 Weston Road import from India?

Apotex Inc. -4100 Weston Road imports 2 pharmaceutical products across 1 categories. Top imports: Apixaban ($4.5M), Rivaroxaban ($499.7K).

Who supplies pharmaceuticals to Apotex Inc. -4100 Weston Road from India?

Apotex Inc. -4100 Weston Road sources from 1 verified Indian suppliers. The primary supplier is Apotex Research Private Limited (100.0% of imports, $5.6M).

What is Apotex Inc. -4100 Weston Road's total pharmaceutical import value?

Apotex Inc. -4100 Weston Road's total pharmaceutical import value from India is $5.0M, based on 106 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Apotex Inc. -4100 Weston Road focus on?

Apotex Inc. -4100 Weston Road imports across 1 categories. The largest: Cardiovascular (100.0%).

Get Full Apotex Inc. -4100 Weston Road Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.